Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech

Novartis loses another NIBR exec as neuro expert Shanker joins a gene therapy biotech

Source: 
Fierce Biotech
snippet: 

Novartis' Gopi Shanker, Ph.D., is the latest R&D leader to exit the Swiss pharma giant as he takes up the helm of chief scientific officer at gene therapy startup Tevard Biosciences.